Category Archive: Venture Capital

Jun 13

The ILSI-BioMed Israel Conference Continues to Grow

ILSI-BioMed

The 11th annual ILSI-BioMed 2012 Conference, also known as National Life Science and Technology Week, was held in Tel Aviv, Israel on 21-23 May 2012. Throughout the many years of attendance, we’ve seen exciting growth in diverse fields of technology at this conference. The ILSI-BioMed conference attracts as many as 6,000 industry players, engineers, and …

Continue reading »

Jun 28

Biotech Funding: Still Playing Hard-to-Get

After a few lean years, biotechs raised $25 billion in 2010.  For the majority of small companies however, funding remains difficult to find.  Ernst & Young’s annual report on the biotechnology industry, Beyond Borders, was recently released and it paints a less rosy picture than the $25 billion number would appear to. It turns out …

Continue reading »

May 27

Bridging the Valley of Death: Bringing New Drugs from the Bench to the Clinic

Bridge

To bring a new medicine to the stage of clinical trial testing requires on the order of $500,000 to one million dollars and then seven to ten years of clinical trials and around $800 million dollars before getting to market.  However, it is doable, and one can point to successful biotechs such as Genentech, Amgen, …

Continue reading »

May 11

Conference Recap – BayBio 2011

The BayBio Annual Conference 2011 was held on 20-21 April 2011 in Burlingame, CA.  The event was attended by more than 1,000 San Francisco Bay Area biotech and life sciences professionals from over 400 companies. This year’s conference focused on funding trends and emerging markets in the life sciences industry.  In keeping with BayBio’s spirit …

Continue reading »

Feb 28

Recap of the 20th CED Biotech/Life Sciences Conference

The 20th Annual Council for Entrepreneurial Development (CED) Biotech/Life Science Conference was held on 21-22 February 2011 in Raleigh, North Carolina.

Dec 07

Biotech Financing: Those That Adapt to Change Will Survive

In the October issue of Biotechnology Focus, Cato Research’s very own Chief Financial Officer and Principal of Cato BioVentures, Daniel Pharand, discusses the recent shift and latest trends in financing within the biotechnology industry.  “There have been a number of trends in the biotech funding world since its last bubble and bust in the early …

Continue reading »

Oct 26

2010 Mid-Atlantic Bio Conference

Image via Wikipedia The 2010 Mid-Atlantic Bio conference will be held in Bethesda, MD from Wednesday, 27 October to Friday, 29 October.  Mid-Atlantic Bio is now in its sixth year and has become one of the country’s premier bioscience and investor conferences. The Mid-Atlantic Bio conference program combines networking events and education sessions to offer …

Continue reading »

Jul 12

Give Your Scientists an Edge – Partner with a CRO!

Image via Wikipedia In the fast paced R&D world, every biotech is looking for an edge to keep them ahead of their competitors and to help them achieve their goal of either getting a drug to human clinical trials or to a stage that attracts a big pharma partner.  In my 10 years of experience …

Continue reading »

Jul 01

Use A Detailed Development Plan to Secure Venture Capital

It’s a tough time to be asking for money.  Whether you’re a high schooler who needs cash to gas up the ride or a fledgling biotechnology company with a hot technology, there’s not much extra to go around.  In today’s stiflingly competitive biotechnology financing market an on-target presentation to a potential investor can make the …

Continue reading »

Mar 05

Help me help you – What makes a good RFP?

As a company transitions from initial product discovery into the nonclinical and clinical aspects of drug/biologic development, it needs to make critical decisions concerning who its outsourcing partner is going to be.  Since capital is typically tight for smaller companies, it’s crucial that every dollar spent results in a value-added outcome.  An important step in …

Continue reading »

Older posts «